This Weekly’s Hot Topics
We have been made aware that various payers are beginning to implement policies that place step-edits for Intravenous Iron Therapy drugs. The step-edits force patients to try and fail on older treatments before having access to newer, more effective treatments. Have you experienced this? If so, how is this affecting your practice? To read more click here and go to MOASC News.
California oncology supports Assembly Bill 32 Telehealth (AB 32). AB 32 would allow for California patients with cancer to continue receiving necessary care through telemedicine. Committee passage of AB 32 would be a big step forward in assuring patients can continue receiving care they need. Contact your Assembly Member today to encourage them to pass this bill. To read more click here and go to California News.
The FDA is holding a three-day meeting this week to review the safety and efficacy of cancer drugs approved through an accelerated pathway to determine whether the drugs have lived up to their makers’ promises. The FDA will hear from Bristol Myers Squibb, Merck and Roche, and a panel of experts will advise the agency whether to revoke any indications for Opdivo, Keytruda and Tecentriq. To read more click here and go to National News.
To read the complete California Oncology Weekly Newsletter, click on the date below.
This Weekly’s Hot Topics
TOMORROW! Encore presentation about COVID-19 Vaccines MOASC News
Pfizer begins study of oral drug as a treatment for COVID-19 Industry News
TOMORROW! Webinar on Pyruvate Kinase Deficiency Industry News
MOASC held its Annual Oncology Summit on March 27. With more than 150 attendees listening to nationally recognized speakers from City of Hope, UCLA and UCSD discussing current management strategies and exciting advances in Breast, Colorectal, Kidney, Lung, Lymphoma and Management of Toxicity from Immunotherapy. To read more click here and go to MOASC News.
All Californians ages 16 and older will be eligible to receive the Covid-19 vaccine starting April 15. Gov. Gavin Newsom announced Thursday that the state would do away with its vaccine eligibility tiers earlier than anticipated. People 50 and older will get a head start, with vaccines opening to them April 1, state officials said. To read more click here and go to California News.
Democrats are aligned behind the idea of allowing HHS to negotiate the price of brand-name drugs in Medicare to reduce costs, but they would need Republican support in the US Senate to pass any legislation. To read more click here and go to National News.
United Healthcare will no longer print and mail paper provider remittance advice (PRAs) and medical prior authorization letters to in-network health care professionals, later this year. In states, and for plans where allowed, health care professionals and facilities will receive emails and be shown where they can view and search for what they need in Document Vault. In response to feedback from health care professionals, UHC will begin the process of transitioning paper claim submissions to electronic submissions through their downloadable payment information for health care professionals and facilities who enroll in Automated Clearing House (ACH)/direct deposit through Optum Pay. To read more click here and go to National News.
To read the complete California Oncology News, click on the date below.